Research Paper Volume 13, Issue 8 pp 11083—11095

circUBAP2 exacerbates malignant capabilities of NSCLC by targeting KLF4 through miR-3182 modulation

class="figure-viewer-img"

Figure 1. (A) RT-PCR detection of circUBAP2_046 and UBAP2 mRNA expression level in A549 cell line with/without treatment of RNase. (B) Detection of circUBAP2_046 and UBAP2 mRNA level by treatment of actinomycin-D after 0h, 6h, 12h, 18h, 24h. (C) RT-PCR analysis of circUBAP2_046 intracellular localization.